Streaming issues? Report here
Clement Manyathela 1500 x 1500 2020 Clement Manyathela 1500 x 1500 2020
The Clement Manyathela Show
09:00 - 12:00
volume_up
volume_mute

Up Next: The Midday Report with Mandy Wiener
See full line-up
The Clement Manyathela Show
09:00 - 12:00
Home
arrow_forward
Local

Cipla plans to bring COVID-19 treatment remdesivir to SA at an affordable price

6 July 2020 5:18 PM
Tags:
Cipla
Coronavirus
COVID-19

Joanne Joseph spoke to Cipla South Africa CEO Paul Miller to find out more.

Drug manufacturer Cipla plans to bring its generic version of Gilead Science’s remdesivir to South Africa this month.

Remdesivir is the first drug to have been approved by US authorities to treat COVID-19 and is shown to speed up the recovery of hospitalised patients.

Cipla South Africa CEO Paul Miller says the medicine is quite pricey but Cipla plans to bring it at an affordable price.

In America, Gilead sells it at about $390 a vial and you would probably take between six or 10 vials depending upon your length of stay in hospital.

Paul Miller, CEO - Cipla South Africa

What we have done as Cipla is we have managed to manufacture this in India as an injectible and we are bringing it at a very affordable price of $55 per vial. We're hoping that this is going to make the medication affordable and accessible.

Paul Miller, CEO - Cipla South Africa

A physician has made an application locally and we are working with the health authorities now to get that approval through so we can bring the product to market.

Paul Miller, CEO - Cipla South Africa

Click on the link below to hear more....




6 July 2020 5:18 PM
Tags:
Cipla
Coronavirus
COVID-19

More from 947 COVID-19 updates, tips, & information